BioReliance is a contract services company that provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services to the pharmaceutical and biopharmaceutical industries worldwide.
"To date, we have successfully served the Indian biopharmaceutical marketplace through our UK offices," said Jarlath Keating, Senior Director of Sales, North America and Asia Pacific.
"However, at this time when the Indian biomanufacturing market is growing in experience and reach, it is clear that having a local presence will be the best manner in which to support our clients for the future. We look forward to working more closely with the businesses in this important region and assisting them in growing their global presence," added Keating.
"Opening a liaison office in India will provide a distinct business advantage for BioReliance," said David Walker, Vice President and Chief Financial Officer. He added that this step will enhance their global footprint specially in the Asia-Pacific region.